CytoNiche
Pioneering 3D micro-organization engineering for advanced stem cell solutions, inspired by Tsinghua University's innovative achievements.
Pioneering 3D micro-organization engineering for advanced stem cell solutions, inspired by Tsinghua University's innovative achievements.
CytoNiche is a biotechnology startup that focuses on pioneering 3D micro-organization engineering for advanced stem cell solutions. Inspired by Tsinghua University's innovative achievements, the company specializes in harnessing 3D micro-organization engineering technology. Leveraging proprietary research, CytoNiche has introduced a suite of innovative products and services, including bespoke, large-scale, automated, and intelligent stem cell cultivation. These offerings encompass the amplification process, regenerative treatments with 3D stem cell micro-tissues, and high-throughput drug screening products using 3D cell models. Established in 2018, the company operates within the industries of biotechnology, health care, life sciences, and VR/AR. In its latest investment round, CytoNiche secured a $10.00K grant investment on 05 July 2023 from the BRICS-Singapore entrepreneurship competition.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $10.00K | 1 | BRICS-Singapore entrepreneurship competition | 05 Jul 2023 |
| Series B | CNY300.00M | 9 |
|
03 Mar 2022 |
| Series A | Unknown | - | 03 Sep 2020 | |
| Series A | Unknown | - | 22 Aug 2019 |
No recent news or press coverage available for CytoNiche.
We care about your data, and we'd love to use cookies make your experience better.
